People who struggle with depression could face a higher risk of diabetes, according to new research from Diabetes U.K., a British charity that aims to improve the care and treatment of people with diabetes. The researchers discovered that people with a history of depression are more susceptible to developing type …
Read More »No more injections? New pill could replace Ozempic and Wegovy for weight loss
An oral weight loss pill has performed well in clinical trials, positioning it as a potential alternative to injectable GLP-1 medications like Ozempic and Wegovy. The Eli Lilly drug, called orforglipron, demonstrated “meaningful weight loss” and cardiometabolic improvements, according to a press release. The phase 3 ATTAIN-1 trial, which was …
Read More »Experts sound alarm as weight-loss shortcut could put Americans at risk
As demand for GLP-1 medications continues to skyrocket for weight loss and diabetes, more Americans are skipping pharmacies and turning to unregulated sellers as a way to avoid high prices, insurance barriers and recurring shortages. The U.S. Food and Drug Administration has warned that so-called “gray market” GLP-1s (such as …
Read More »Ozempic and similar drugs could interfere with common medical procedure, research warns
Researchers have revealed a surprising new side effect linked to GLP-1 agonists, such as Ozempic, Wegovy, Mounjaro and Zepbound. These popular treatments for diabetes and obesity could interfere with medical imaging, such as PET and CT (“CAT”) scans. CT scans are often used to get detailed internal images to detect …
Read More »Scientists reveal how your favorite soda could quietly mess with your mood
Even one or two sodas a day could be disrupting your gut health enough to affect your mood, a new study has found. Researchers in Germany examined more than 900 adults — about half with clinical depression and half without — and found that those who drank more soft drinks …
Read More »